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Abstract 
In recent years there appears a variety of new and innovative applications of the dried blood spots. The areas of 
their range of application are medicine, neonatology, virology, microbiology, toxicology and pharmacokinetics, 
metabolic exchange, therapeutic drug monitoring, toxicology, and control of environmental pollution. The 
advantages of DBS technology can be combined into four main groups: (1) compared to conventional 
venipuncture, requires less blood volume, which is especially important in pediatrics and neonatology; (2) the 
procedure for blood collection is easy, inexpensive and noninvasive; (3) the risk of bacterial contamination or 
hemolysis is minimal; and (4) DBS can be maintained for a long time with almost no impact on the quality of 
the analysis. In recent years is increasing the application of DBS as method for seroepidemiological survey with 
focus viral infections: measles, mumps, rubella and hepatitis B virus. The DBS technique is optimized as an 
alternative approach (non-invasive, inexpensive, not requiring trained staff and cold chain for transport and 
storage) of venipuncture collection of clinical material in virology.  
------------------------------------------------------------------------ 
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This method facilitates the scientific researches about the concentration of virus specific antibodies in peripheral 
blood taken from a finger or heel; determining the percentage susceptibility / protection of the studied group of 
patients againt vaccine-preventable infectious - measles, mumps, rubella and hepatitis B; social benefits - non-
invasive technique for testing of small children and infants and applications in regions in the countries with not 
well developed logistics infrastructure. 
Keywords: dried blood spots; viral agents; serological assay; molecular test.  
1. Introduction  
The idea of using blood collected on paper map made of cellulose attributed to Ivar Christian Bang (1869 - 
1918), considered the founder of modern clinical microanalysis [1; 2]. In 1913, Bang determine glucose in 
eluates from dried blood spots (DBS) and performs measurements of nitrogen using the Kjeldahl method again 
with the technique of filter paper [2; 3]. Subsequently, several researchers reported the use of dry blood spots in 
serological tests for the diagnosis of syphilis [2]. In 1924, Chapman [4] summarizes the advantages of DBS 
technique, stressing four key items that are still valid today: (1) compared to conventional venepuncture, 
requires less blood volume, which is especially important in areas such as paediatrics and neonatology; (2) the 
procedure for blood collection is easy, inexpensive and non-invasive; (3) the risk of bacterial contamination or 
haemolysis is minimal; and (4) DBS can be maintained for a long time with almost no impact on the quality of 
the analysis. Besides their use for detection of syphilis, subsequently began to talk about applications of this 
technique for the detection of antibodies against measles, mumps, polio virus, parainfluenza virus and 
respiratory syncytial virus in 1953 [2] and also for the identification of Shigella in stool dried (feces) on filter 
paper [5]. In 1969/70s Guthrie published his famous method for neonatal screening for phenylketonuria of DBS 
obtained by pricking the heel of newborns [6] later and surveillance of congenital hypothyroidism and sickle 
cell disorders [6; 7]. Approach using capillary blood obtained by heel or finger and soaked on filter paper 
(Guthrie card), applies to screen metabolic disease in a large population of newborns in Scotland and Susie 
Guthrie in 1963 [6]. Another type of application stored on filter paper blood is the detection of markers of a 
disease, such as acyl CoA dehydrogenase [8], human chorionic gonadotropin in cases of Down syndrome [9], 
and glycated haemoglobin in insulin dependent diabetes mellitus [10] as well as for evaluation of drug levels 
[11; 12; 13]. 
2. The applications of DBS in medicine and laboratory diagnostics 
There are many reports of the applicability of DBS in medicine. Since 2005 again research focus to DBS, as 
builds a variety of new and innovative applications. This led to an almost exponential increase in the number of 
scientific publications in the field of DBS. Areas that fall within their range are toxicology and 
pharmacokinetics, metabolic exchange, therapeutic drug monitoring, forensic toxicology studies, and control of 
pollution [14; 15]. The use and scientific data about dried blood spots in virology are scarce, mainly due to the 
limitations of sensitivity and specificity in the screening of such small volumes of blood (equivalent to 5-10 U / 
mL) [12; 16; 17] (Table 1). 
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Table 1: Type analysis by DBS technique (according to http://www.spotonsciences.com/dbstechnology/) 
Class Molecules Specific Analysis 
Small molecules amino acids, drugs, hormones, peptides 
Nucleotides DNA, miRNA, mRNA, RNA, virus DNA, virus 
RNA 
Proteins hemoglobin, cytokines, immunoglobulins, etc. 
 
In the past few years, DBS analysis makes triumphant procession in clinical laboratory diagnostics and 
chemistry. In some countries has formulated a national standard for the collection of blood on filter paper as 
newborn screening [18] but the preanalytic phase of DBS analysis is undervalued and not well optimized. Dried 
blood spot sampling has been used to screen newborn babies for congenital metabolic diseases for over 50 
years. A spot of blood from a heel stick of the infant is placed on filter paper and allowed to air dry.  
A circular punch (about 3 mm) is removed, eluted with solvent and analyzed for metabolic markers. More than 
50 separate analyses can be measured from a quarter size spot of blood, mainly due to adoption within the last 5 
years of mass spectrometry for analysis. 
DBS sampling also contributes to the generation of higher quality data in pre-clinical studies because more time 
points can be added without the need for additional rodents and the technology allows for serial 
pharmacokinetic profiling. In addition, DBS allows for pre-clinical juvenile toxicology studies to be conducted 
in small animals where the availability of blood has always been a problem.  
Advantages of DBS sampling include minimal volume requirements (approximately 30 – 100 µL per spot), ease 
of sample attainment by finger or heel stick with minimal training required, and ease of transport and sample 
stability. Once dried, the sample is stable for months to years at ambient temperature or under refrigeration [19; 
20]. 
These superior traits have made DBS a common sampling method for gene screening and long-term genetic 
sample bio-banking. Within the last few years, DBS sampling has been used for clinical and pre-clinical 
pharmacokinetic studies, taking advantage of smaller sampling needs and simplified sample collection and 
handling. DBS sampling has also been used for disease surveillance in developing countries [21]. 
The presence of clinical samples which can be easily collected, stored, transported and archived is particularly 
important, especially in areas that do not have adequate infrastructure for processing of blood products. 
Moreover, the receipt of necessary amount of blood from newborns can be accompanied by many difficulties. 
The venepuncture is relatively invasive procedure that should be performed by trained staff, required materials 
and equipment; blood samples must be promptly processed and stored under controlled conditions. An analysis 
with the use of whole blood dried on filter paper can provide a viable alternative (Table 2). 
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Table 2: Comparison of blood collection methods (venipuncture and DBS) and advantage of DBS technology 
No Feature Venipuncture DBS 
1. Remote sample collection No Yes 
2. 
 
3. 
 
4. 
5. 
6. 
 
7. 
 
8. 
Stable and transportable at 
ambient temperature 
Ease of use with minimal 
training required 
Small collection volume 
Patient collection by finger stick 
Quick drying for enhanced 
sample stability 
Protection from humidity and 
contamination 
Integrated collection and storage 
No 
 
No 
 
No 
No 
NA 
 
NA 
 
No 
Yes 
 
No 
 
Yes 
Yes 
Yes 
 
Yes 
 
Yes 
 
In recent years is increasing the application of DBS as method for seroepidemiological survey with focus viral 
infections: measles, mumps, rubella and hepatitis B virus. These four infections are vaccine-preventable 
diseases and are a major cause of morbidity and mortality in children worldwide. The high contagious index 
(>90% for measles and rubella, and >50% for mumps), the presence of heavy, leading to debilitating 
complications with high frequency and determine their health and socio-economic importance. Approximately 
30% of reported cases of measles have one or more complications, such as disabling effects are most common in 
children under five. Reports from 2014 inform about 115,000 children (mostly under 5 years of age) deaths due 
to measles infection. This means that about 314 children die every day as a result of complications of this viral 
disease. The importance of rubella infection as a public health is determined by the teratogenic effects of rubella 
virus during pregnancy. There are a high percentage of miscarriages, stillbirths or congenital rubella syndrome. 
Mumps virus caused of meningitis and meningoencephalitis at about 10 to 30% of the infected and non-
immunized against this virus. Hepatitis B virus acts the liver cells and is a major cause for the development of 
liver cirrhosis. According to data from 2000 reported cases of acute hepatitis B infection in the world are nearly 
5.7 million, of which 521 000 - deaths. Adults, who suffered HBV, usually recover completely, but the infection 
can be a cause for the development of chronic carrier in infants and babies [22]. 
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These viral infections weaken the immune system and open the door to secondary health problems such as 
pneumonia, blindness, diarrhea, encephalitis and etc. Children in poor areas of countries including malnourished 
and with uncontrolled personal and health care are particularly vulnerable to permanent damage, even with 
visible recovery. The severity and consequences of the above infections are determined mostly by the 
preliminary preparation of the immune system by vaccination and / or previous infection. 
In 1998, the Regional Committee of the World Health Organization (WHO) for Europe defined as key and 
target objects of health policy nine vaccine-preventable diseases, including elimination of measles and reduce 
the incidence of congenital rubella syndrome (CRS) [23]. Even in the first decade of the 21st century, amid 
reached a low morbidity, outbreaks of measles and rubella are registered in several countries of Western and 
Central Europe. In Bulgaria 2009-2011, after long period without outbreaks (7 years) was developing one of the 
largest epidemics in the region - over 24,000 infected (infected - 24,365; morbidity - 324% ooo) and 24 died 
(mortality - 0.3% ooo, lethality - 0,1%) [24]. In the period 2011-2013, major measles outbreaks were registered 
in France, Ukraine, Georgia and Turkey. In 2012-2013 were reported a threefold increase of the incidence of 
rubella in Europe. In 2015 in the European region measles outbreaks were reported in Germany, Bosnia and 
Herzegovina, Serbia, France, Austria and Turkey (total number of infected were more than 7000), about rubella 
mainly in Poland with more than 2000 infected (nearly 86% of all registered by rubella in the region) and 
mumps in Poland, Great Britain, Spain, Germany, with more than 10,000 reported cases [22; 25]. 
According [26] measles, rubella and mumps are typical anthropology infections by clinical criteria for detecting 
and proving the disease are: 
• Measles - generalized rash lasting more than three days, a temperature higher than 38oC and one or 
more of the following symptoms: cough, runny nose, Koplik spots, conjunctivitis. 
• Mumps - acute onset of unilateral or bilateral painful swelling of the parotid or other salivary gland, 
lasting more than two days. 
• Rubella - acute onset of generalized maculopapular rash and arthralgia / arthritis, lymphadenopathy, or 
conjunctivitis. 
The laboratory diagnosis is based on: detection of IgM antibodies or specific antibody response against measles, 
mumps or rubella in the absence of recent vaccination; detect the virus (non-vaccine strain) or viral nucleic acid 
in an appropriate clinical material. The collection of blood samples, particularly from children, is not always 
greeted with enthusiasm and maintaining a cold chain when transporting samples to the laboratory is not always 
achievable. Recently two approaches have been validated for use in the WHO Measles and Rubella Laboratory 
Network which have the potential to be useful tools for the measles/rubella programme; the use of dried blood 
spots and oral fluid samples. Dried blood spots have been used for a range of epidemiological studies as an 
alternative to serum. Antibody is stable in this form and so it is particularly valuable where the lack of a cold 
chain is an issue. This technique has recently been applied successfully to measles cases, and there is 
accumulating evidence that the technique will work as well for rubella cases [26]. 
Hepatitis B viral infection (HBV) that attacks the liver and can cause both acute and chronic disease. HBV is 
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transmitted through contact with the blood or other body fluids of an infected person. Although 95% of acute 
HBV infections occur in rescue, 5% of them pass into a chronic form [27]. The outcome of hepatitis B virus 
infection is characterized by the development of seroconversion and development of antibodies against surface 
viral antigen HBsAg (anti-HBs) and clears the virus from hepatocytes. In a small percentage of individuals 
accomplished seroconversion in serum and liver detect minor levels of HBV DNA, which are sometimes so low 
that cannot be detected with the available molecular tests, a condition described as occult or latent hepatitis B 
[28]. HBV reactivation is a clinically significant complication that can occur self-limiting, but in most cases it is 
acute and in 5% to 40% can lead to severe liver complications [29]. More than 686 000 people die every year 
due to complications of hepatitis B, including cirrhosis and liver cancer. The risk of developing chronic hepatitis 
B is greatest when virus infection occurs at an earlier age. 80–90% of infants infected during the first year of life 
develop chronic infections and 30–50% of children infected before the age of 6 years develop chronic 
infections. 
The health system there are effective live (MMR vaccine) and recombinant (hepatitis B vaccine) virus vaccine, 
monovalent or combination, which provide 90-95% immunity against infectious agents. The main reason for the 
failure to control measles, mumps, rubella and hepatitis B virus is insufficiently vaccine coverage which creates 
the risk of disease on older age with more severe course and higher mortality. Despite the advantages of the 
vaccination it creates an opportunity for variability of wild viruses and reactions in the body that cause. Viral 
infections such as measles, mumps and rubella can have clinically and immunologically atypical reactions. 
In recent years a growing and more affordable trips around the world, refugee crisis and anti-vaccination 
activities, increases the risk of formation of "landfill" from unprotected people and revival of considered 
endangered infections. In this regard scientific developments in order to enrich the knowledge of the viral nature 
and course of action are subject to the interest of many scientists. 
In view of the widespread importance included in the current draft infections and the development of 
approaches (methods and equipment) in science, pressing need for alternative methods for the detection of 
measles, rubella, mumps and hepatitis B viruses. This would provide a foundation for further scientific 
developments in object other significant public health pathogens. 
Collecting venous blood samples as a "gold standard" in the diagnosis of measles, rubella, mumps and hepatitis 
B virus, especially by children, is not always acceptable and often creates discomfort (pain, injection vacuum 
system, trained staff, maintenance of cold chain and etc.). This necessitates the search for alternative samples 
(dried blood spots and oral fluid) and techniques to detect of these viruses and specific antibody against them. In 
these samples viral agents and specific antibodies are present in stable form and can be archived, which is 
valuable in the absence of refrigeration circuit. The approaches are non-aggressive and more acceptable to the 
public (including young children, pregnant women, etc.) [30-33]. Sampling from remote, non-laboratory 
locations can be difficult due to the need for hours of air drying in a protected area and awkward handling with 
multiple components (i.e. lancets, filter paper cards, drying rack, and shipping containers). Additionally, proper 
application of blood to the filter paper requires training to reduce artifacts due to uneven sample coverage; 
touching the paper, too large or too small of a drop or too much time between drops can make a sample not 
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suitable for analysis. These difficulties have severely limited the ability of a patient to self-collect a sample from 
home or any remote location. 
The optimizing of alternative approaches would provide valuable information in medical science and biology of 
viral infections. This line of research would be basis for future broader seroepidemiological survey on 
population level. 
Since the opening of DBS technology at the beginning of the XX-th century up to now a number of research 
teams working in the direction of their wider application in various fields and improving the chemical structure 
of the used cellulose matrix. Currently it has developed a new generation of cards of filter paper (Whatman FTA 
elute cards) - acronym for rapid analysis technology serum samples and nucleic acids. 
Uzicanin A. et. al. [34] and Helfand R. et. al. [35] published studies seroepidemiological importance of DBS in 
control and monitoring of measles and rubella infection. The authors reported test sensitivity and specificity 
over 90% and prove their real alternative to serum samples, particularly in epidemic situations. 
Grüner and his colleagues 2015 provided protocol step by step [36-38] for use of DBS in immunological and 
molecular studies, comprising the following steps: (1) collecting blood; (2) preparation of blood spots; (3) 
drying the blood spots; (4) storage and transport; (5) elution of whole blood and/or serum from the DBS; and 
finally (6) an analysis of DBS eluates (Figure 1). This protocol is based on 1 762 related pairs serum/DBS for 
detection of hepatitis B - surface antigen (HBsAg), antibodies against HBV core antigen (anti-HBc), antibodies 
against HBV surface antigen (anti-HBs), HBV DNA, antibodies to hepatitis C virus (HCV) (anti-HCV), HCV 
RNA, and human immunodeficiency virus (HIV) 1-p24-antigen / anti-HIV 1/2 [36]. Subsequently, the protocol 
used in the pilot study "Drugs and Chronic Infectious Diseases" ("DRUCK Study"), which was conducted by 
the Robert Koch Institute in close cooperation with the National Reference Centre for hepatitis C [39]. 
3. Methods for collection and laboratory testing of DBS 
Dried blood spots can be collected by pricking a finger or heel using sterile automatic lancets (1.5 - 2 mm). 
Blood stains will be stored on the cards of filter paper (Sample Collection Cards suitable for biological fluids, 4 
rounds, and 13 mm), labelled and drying at room temperature for 30 minutes. The cards have the opportunity to 
collect 4 or 5 spots and each round can accommodate 75-80 μl of sample, they are ready for use, labelling, 
transport and archiving without the need freezing in a freezer or dry ice. Storage - ziplock bags with desiccant to 
20C - 80C.  
3.1. The necessary equipment is no specific 
3.2.  cards filter paper, rotary centrifuge, laboratory shaker, and freezer 
3.3. The extraction methods for elution of whole blood and serum from dried blood spots 
The method for elution of whole blood and serum from dried blood spots has the following basic steps to work: 
(Figure 1): 
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• Punched single spot (DBS) with size 6 mm from each round of the cards of filter paper with the help of 
a perforating device. Transferring of all perforated dried blood spots from a patient in a single well of a 
12-well plate. 
• Add phosphate-buffered saline containing 0.05% Tween 20 and 0.08% sodium azide. Calculating the 
volume of the added buffer in accordance with the requirements of the analysis. 
• Attaching the plate with the DBS and phosphate-buffered saline in a laboratory shaker and elution for a 
minimum of 4 hours. 
• On the next day remove blood and haemolytic supernatant. Transfer of eluates in microcentrifuge 
tubes. Centrifuge for 2 minutes at 10 500 rpm, for the release of the supernatant and purifying the 
eluate. 
 
(A) 
 
(B) 
Figure (1) Scheme of the extraction test procedure for the isolation of whole blood and serum from DBS (A) 
and advantage of DBS technology (B) 
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4. Conclusion 
The DBS technique is optimized as an alternative approach (non-invasive, inexpensive, not requiring trained 
staff and cold chain for transport and storage) of venipuncture collection of clinical material in virology. This 
method facilitates the scientific researches about the concentration of virus specific antibodies in peripheral 
blood taken from a finger or heel; determining the percentage susceptibility / protection of the studied group of 
patients against vaccine-preventable infectious - measles, mumps, rubella and hepatitis B; social benefits - non-
invasive technique for testing of small children and infants and applications in regions in the countries with not 
well developed logistics infrastructure. 
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